Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway

Cancer Research

Volumn 62, Issue 13, 2002, Pages 3842-3849

  Farhana, Lulu ^a   Dawson, Marcia ^b   Rishi, Arun K ^a   Zhang, Yuxiang ^a   Van Buren, Eric ^a   Trivedi, Charu ^a   Reichert, Uwe ^c   Fang, Guowei ^d   Kirschner, Marc W ^d   Fontana, Joseph A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

^c Galderma R and D   (France)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; CYCLIN B; LIGASE; MESSENGER RNA; N ACETYLLEUCYLLEUCYLNORLEUCINAL; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE S PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION;

ACETYLATION; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE PROTEINS; CONSENSUS SEQUENCE; CYCLIN B; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HUMANS; MALE; PROSTATIC NEOPLASMS; RETINOIDS; S PHASE; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UBIQUITIN;

EID: 0036645147     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Retinoids in chemoprevention and differentiation therapy
2. Recent advances in the use of Vitamin A (Retinoids) in the prevention and treatment of cancer
3. An update of biological aspects and clinical applications
4. Expression of retinoic acid receptor-β sensitizes prostate cancer cells to growth inhibition mediated by combination of retinoids and a 19, nor hexafluoride vitamin D3 analog
5. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells
6. A synthetic retinoid CD437 induces S-phase arrest and apoptosis in the human prostate cancer cells. LNCaP and PC-3
7. Deregulated transcription factor E2F-1 expression leads to S phase entry and p53-mediated apoptosis
8. Deficiency of retinoblastoma proteins leads to inappropriate S phase entry, activation of E2F-responsive genes and apoptosis
9. E2F-1 specific induction of apoptosis and p53 accumulation which is blocked by MDM-2
10. Toward an understanding of the functional complexity of the E2F-1 and retinoblastoma families
11. The retinoblastoma protein is phosphorylated on multiple sites by human Cdc2
12. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
13. Collaboration of Gl cyclins in the functional inactivation of the retinoblastoma protein
14. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
15. Regulation of cell proliferation by the E2F transcription factors
16. Autoregulatory control of E2F-1 expression in response to positive and negative regulators of cell cycle progression
17. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation
18. Cyclin A-kinase regulation of E2F- 1 DNA binding function underlines suppression of an S phase checkpoint
19. E2F-1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction
20. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin proteosoma pathway
21. Degradation of E2F by the ubiquitin-proteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming proteins
22. Regulation of E2F through ubiquitin-proteosome dependent degradation: Stabilization by the RB tumor suppressor protein
23. Cell cycle-dependent usage of transcriptional start sites: A novel mechanism for regulation of cyclin Bl
24. Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in Hela cells
25. The inhibition of cyclin B1 gene transcription in quiescent NIH3T3 cells is mediated by an E-box
26. Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with a loss of functional CCAAT-binding NF-Y complex
27. Mechanisms and degradation of cyclin B
28. Regulation of the cyclin B degradation by an inhibitor of mitotic proteolysis
29. Constitutive activation of cyclin B1-associated cdc 2 kinase overrides p53-mediated G2-M arrest
30. Synthesis, structure-affinity relationships and biological activities of ligands binding to retinoic acid receptor subtypes
31. Direct binding of CDC 20 protein family members activates the anaphase-promoting complex in mitosis and G1
32. The checkpoint protein MAD2 and the mitotic regulator CDC 20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation
33. Flow cytofluorimetry: Discrimination between single cell and cell aggregates by direct size mesurements
34. S phase arrest and apoptosis induced in normal mammary cells by a novel retinoid
35. 0 arrest and apoptosis induced by a novel retinoid in human breast cancer cells
36. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation
37. Residues phosphorylated by TFII H are required for E2F-1 degradation during S-phase
38. Regulation of E2F-1 activity by acetylation
39. The anaphase-promoting complex: New subunits and regulators
40. CDC 20 and CDH1: A family of substrate-specific activators of APC-dependent proteolysis
41. Yeast Het 1 is a regulator of CLb2 cyclin proteolysis
42. Control of cyclin ubiquitinization by CDK-regulated binding of Hct 1 to the anaphase promoting complex
43. Mitotic regulation of the APC activator proteins CDC 20 and CDH 1
44. The regulation of Cdc 20 proteolysis reveals a role for APC components Cdc 23 and Cdc 27 during S phase and early mitosis
45. Phosphorylation of Cdc 20/fizzy negatively regulates the mammalian cyclosome/APC in the mitotic checkpoint
46. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events
47. Translocation of cyclin B1 to the nucleus at prophase requires a phosporylation dependent nuclear import signal
48. Combinatorial control of cyclin B1 nuclear trafficking through phosphorylation at multiple sites
49. Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F-1 by multiple ROC-cullin ligases
50. Apoptosis. Induction of DNA synthesis and apoptosis are separable functions of E2F-1
51. Gene therapy for gliomas: P53 and E2F-1 proteins and the target of apoptosis
52. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53
53. E2F-1-induced p53 independent apoptosis in transgenic mice
54. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene
55. Distinct roles for E2F proteins in cell growth control and apoptosis
56. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis
57. Increased levels of E2F-1-dependent DNA binding activity after UV-or γ irradiation
58. E2F family members are differentially regulated by reversible acetylation
59. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor independent pathway
60. Induction of apoptosis in human non-small cell lung carcinoma cells by a novel synthetic retinoid CD437
61. Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways
62. Effects of receptor class- and subtype-selective retinoids and an apoptosis inducing retinoid on the adherent growth of the NIH-OVCAR-3 ovarian cancer cell line in culture